Rheumatic Fever

Molecular mimicry causes immune responses aimed at group A Streptococcus components to cross-react with certain human tissues. This misdirected response can affect the heart, joints, skin, and central nervous system, producing different clinical features in the same illness. The mechanism explains why tissue inflammation may appear after the original infection rather than during the throat infection itself.

These manifestations reflect the distribution of tissues affected by the cross-reactive immune response. Inflammation involving the heart may produce carditis, while joint involvement can appear as migratory arthritis. Skin findings and chorea indicate effects involving the skin and central nervous system, respectively. Recognizing this multisystem pattern helps clinicians connect apparently different findings to one post-infectious process.

Preventing recurrence matters because repeated attacks are associated with ongoing risk of rheumatic heart disease. Long-term secondary prophylaxis reduces the likelihood of further episodes after rheumatic fever has occurred. This preventive strategy is especially important when the disease affects children or adolescents, because reducing recurrent inflammation can help limit later cardiac consequences.

The revised Jones criteria organize the clinical assessment of suspected rheumatic fever by evaluating characteristic manifestations and combining them with evidence of a recent group A Streptococcus infection. The criteria help clinicians interpret findings such as carditis, migratory arthritis, rash, or chorea in a structured way rather than relying on one symptom alone.

Prompt antibiotic treatment addresses the preceding group A Streptococcus infection, while long-term secondary prophylaxis focuses on preventing additional rheumatic fever attacks. These measures serve different points in the disease course: one acts early after the infection is recognized, and the other provides continuing prevention after rheumatic fever has developed. Together, they reduce preventable cardiac harm.

Rheumatic fever is particularly important in children and adolescents because it can become a preventable cause of heart disease during these years. Clinical care therefore emphasizes recognizing the characteristic inflammatory manifestations, confirming recent streptococcal infection, and maintaining secondary prophylaxis when indicated. These steps aim to reduce recurrent attacks and the later development of rheumatic heart disease.